XML 44 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note A - Organization and Summary of Significant Accounting Policies (Details Textual)
$ / shares in Units, € in Millions
12 Months Ended
Aug. 07, 2017
shares
Jun. 30, 2018
USD ($)
$ / shares
shares
Jun. 30, 2017
USD ($)
$ / shares
shares
Jun. 30, 2018
EUR (€)
shares
Sep. 30, 2017
USD ($)
Foreign Currency Contract, Asset, Fair Value Disclosure   $ 55,000      
Foreign Currency Contracts, Liability, Fair Value Disclosure   55,000 $ 521,000    
Notes, Loans and Financing Receivable, Net, Current, Total   1,500,000    
Investment Income, Interest   1,085,000 459,000    
Impairment of Long-Lived Assets to be Disposed of   0 0    
Sales Discounts, Noncash   898,000    
Royalty and Licensing Revenue   21,400,000 26,900,000    
Royalty Expense   854,000 1,000,000    
Research and Development Expense, Total   1,500,000 1,600,000    
Advertising Expense   2,400,000 598,000    
Liability for Uncertainty in Income Taxes, Current   0 $ 0    
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount   $ 0      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares   0 0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares   0 0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value   $ 0 $ 0    
Accounts Receivable [Member] | Customer Concentration Risk [Member]          
Concentration of Risk Number of Major Customers   3      
Concentration Risk, Percentage   76.60% 65.60%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Beta Alanine Raw Material Sale Customers [Member]          
Concentration Risk, Percentage   17.30% 21.30%    
2009 Omnibus Stock Incentive Plan [Member] | Board of Directors and Management Members [Member]          
Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares   175,000 155,000    
Restricted Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number, Ending Balance | shares   458,012 319,355 458,012  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options   $ 3,100,000      
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition   2 years 219 days      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares   $ 10.19 $ 8.82    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares   41,661 0    
Restricted Stock [Member] | 2009 Omnibus Stock Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares   $ 11.30      
Employee Stock Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate   0.00%      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares     0    
Foreign Exchange Contract [Member]          
Derivative, Notional Amount   $ 34,400,000   € 29  
Derivative, Remaining Maturity   1 year 60 days      
Minimum [Member]          
Property, Plant and Equipment, Useful Life   1 year      
Minimum [Member] | Restricted Stock [Member] | 2009 Omnibus Stock Incentive Plan [Member] | Board of Directors and Management Members [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   3 years      
Maximum [Member]          
Property, Plant and Equipment, Useful Life   39 years      
Maximum [Member] | Restricted Stock [Member] | 2009 Omnibus Stock Incentive Plan [Member] | Board of Directors and Management Members [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period   5 years      
Kaged Muscle LLC [Member] | Notes Receivable [Member]          
Notes, Loans and Financing Receivable, Net, Current, Total         $ 1,500,000
Notes, Loans and Financing Receivable, Interest Rate, Stated Percentage         15.00%
Investment Income, Interest   $ 171,000      
Juice Plus + [Member]          
Agreement, Term 5 years        
Juice Plus + [Member] | Restricted Stock [Member]          
Stock Issuance Agreement, Shares Agreed to Grant | shares 500,000        
Sales Discounts, Noncash   898,000      
Fair Value, Inputs, Level 1 [Member]          
Fair Value, Net Asset (Liability), Total   0 $ 0    
Fair Value, Inputs, Level 3 [Member]          
Fair Value, Net Asset (Liability), Total   $ 0 $ 0